Business Standard Natco Pharma shares rise 3% in weak mkt on launching generic Pomalyst in US
The buying on the counter came after Natco Pharma, along with Breckenridge Pharmaceutical, launched Pomalidomide Capsules, a generic version of Pomalyst by Celgene, in the US market.